Erythropoetin in Urologic Oncology

Objectives: The use of erythropoietin (EPO) for the treatment of anemia associated with urological malignancies is not well defined. The rate of anemia is dependent on the type of cancer and on the different types of treatment. Only with a substantial risk for blood transfusion is substitution treat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European urology 2001-01, Vol.39 (1), p.1-8
Hauptverfasser:	Albers, Peter, Heicappell, Rüdiger, Schwaibold, Hartwig, Wolff, Johannes M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Medical sciences Pharmacology. Drug treatments Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!